読み込み中
Myomo, Inc. is a medical technology company specializing in wearable robotics. The company engineers and manufactures advanced myoelectric orthoses, primarily for individuals in the United States who experience neuromuscular impairments. Its flagship product, MyoPro, is an upper-limb brace that utilizes muscle signals to assist patients with weak or paralyzed arms, thereby enhancing their ability to perform daily activities. These devices aim to restore function for both adult and adolescent patients suffering from various neurological conditions, including stroke, spinal cord injury, traumatic brain injury, and brachial plexus injuries. Myomo distributes its innovative solutions through a network that includes orthotics and prosthetics providers, rehabilitation hospitals, the Veterans Health Administration, and additional distributors. Established in 2004, Myomo, Inc. maintains its corporate headquarters in Boston, Massachusetts.
前日終値
$1.43
+$0.02 · +1.42%
日中の時刻はETです。市場データは遅延する場合があります。
Myomo, Inc. is a medical technology company specializing in wearable robotics. The company engineers and manufactures advanced myoelectric orthoses, primarily for individuals in the United States who experience neuromuscular impairments. Its flagship product, MyoPro, is an upper-limb brace that utilizes muscle signals to assist patients with weak or paralyzed arms, thereby enhancing their ability to perform daily activities. These devices aim to restore function for both adult and adolescent patients suffering from various neurological conditions, including stroke, spinal cord injury, traumatic brain injury, and brachial plexus injuries. Myomo distributes its innovative solutions through a network that includes orthotics and prosthetics providers, rehabilitation hospitals, the Veterans Health Administration, and additional distributors. Established in 2004, Myomo, Inc. maintains its corporate headquarters in Boston, Massachusetts.
日中レンジ
現在 $1.43
52週レンジ
現在 $1.43
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
72
割安
センチメント
53
まちまち
リスク
76
高リスク
モメンタム
52
中立
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Myomo, Inc. is a medical technology company specializing in wearable robotics. The company engineers and manufactures advanced myoelectric orthoses, primarily for individuals in the United States who experience neuromuscular impairments. Its flagship product, MyoPro, is an upper-limb brace that utilizes muscle signals to assist patients with weak or paralyzed arms, thereby enhancing their ability to perform daily activities. These devices aim to restore function for both adult and adolescent patients suffering from various neurological conditions, including stroke, spinal cord injury, traumatic brain injury, and brachial plexus injuries. Myomo distributes its innovative solutions through a network that includes orthotics and prosthetics providers, rehabilitation hospitals, the Veterans Health Administration, and additional distributors. Established in 2004, Myomo, Inc. maintains its corporate headquarters in Boston, Massachusetts.
日中レンジ
現在 $1.43
52週レンジ
現在 $1.43
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（USD） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 4092.8万 USD | 3255.12万 USD | 1924.12万 USD | 1555.52万 USD | 1385.64万 USD |
| 売上原価 | 1403.97万 USD | 936.59万 USD | 605.88万 USD | 530.21万 USD | 354.41万 USD |
| 粗利益 | 2688.83万 USD | 2318.53万 USD | 1318.24万 USD | 1025.31万 USD | 1031.23万 USD |
| 研究開発 | 694.38万 USD | 477.2万 USD | 263.65万 USD | 248.25万 USD | 255.74万 USD |
| 販売・一般管理 | 3434.63万 USD | 2462万 USD | 1877.74万 USD | 1844.28万 USD | 1802.3万 USD |
| 営業費用 | 4129.02万 USD | 2939.2万 USD | 2141.39万 USD | 2092.53万 USD | 2058.03万 USD |
| 受取利息 | 47.7万 USD | 38.86万 USD | 41.03万 USD | 8.87万 USD | 1612 USD |
| 支払利息 | 92.78万 USD | — | — | — | — |
| 減価償却費と償却費 | 197.97万 USD | 77.7万 USD | 51.77万 USD | 54.26万 USD | 33.6万 USD |
| 営業利益 | −1440.18万 USD | −620.67万 USD | −823.15万 USD | −1067.22万 USD | −1026.81万 USD |
| 純利益 | −1557.39万 USD | −618.37万 USD | −814.76万 USD | −1072.1万 USD | −1037.23万 USD |
会社概要が更新されました 2026年10月11日.
発表済み実績と利用可能なコンセンサス予想。
発表済み実績と利用可能なコンセンサス予想。
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
この株式へのエクスポージャーを報告している上場投資信託です。
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Extended Market ETFVXF
EA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSMAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
